ST
ADVM

Spot Trading’s Adverum Biotechnologies ADVM Stock Holding History

Spot Trading’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,100
Closed -$255K – 3551
2015
Q3 		$255K Buy
+3,100
New +$396K ﹤0.01% 2519

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Spot Trading's ADVM Position: Q4 2015 in Review

Spot Trading sold out of Adverum Biotechnologies (ADVM) in Q4 2015, closing a stake of 766 shares — an estimated $67.3K sold.

Spot Trading first reported a position in ADVM in Q1 2015 and held it in 2 quarters. The position peaked at $226K in Q1 2015. 76 funds tracked by Wall St. Rank hold ADVM as of Q4 2015.

  • Spot Trading reported no remaining Adverum Biotechnologies position as of Q4 2015 after selling out during the quarter.
  • Spot Trading sold 766 Adverum Biotechnologies shares in Q4 2015, an estimated $67.3K.
  • Spot Trading first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 2 quarters.
  • Spot Trading's Adverum Biotechnologies position peaked at $226K in Q1 2015.
  • 76 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2015.

Based on Spot Trading's 13F filing for Q4 2015, filed 29 Jan 2016.